U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07018024) titled 'Anti-Glomerular Basement Membrane Disease' on June 04.
Brief Summary: This study aims to clarify the prognosis of the rare but severe condition anti-glomerular basement membrane disease (anti-GBM disease also known as Goodpastures disease). Specifically, we aim to investigate how the prognosis is affected by treatment options and disease severity at presentation measured using biomarkers in blood and urine. The study has two arms, one focusing on treatment (A) and one focusing on biomarkers (B). Data from a research subject (patient) can be included in both arms. For inclusion in arm A patients must be diagnosed after 01-01-2010 wit...